Latest News and Press Releases

Iktos appoints new Scientific Advisory Board with world-renowned AI and Drug Discovery experts to accelerate the development of novel therapies Paris (France), 17 October, 2024 – Iktos, a leader in...

PRESS RELEASE Iktos acquires Synsight, a life sciences technology company specializing in protein-protein and RNA-protein interactions-targeted drug discovery Synsight provides Iktos with an...

PRESS RELEASE Italfarmaco partners with Iktos on artificial intelligence to speed drug discovery breakthroughs for patients Combines AI to increase the potential of novel histone deacetylase (HDAC)...

Paris (France), 2nd May 2024 – Iktos, a company specialized in Artificial Intelligence for new drug design, announces the appointment of Roman Fleck as Chairman of the Board. Yann Gaston-Mathé steps...

Paris (France) and Tokyo (Japan), February 14, 2024 – Iktos, a company specialized in Artificial Intelligence for new drug design, announces the opening of Iktos K.K., its new subsidiary in Japan....

Iktos announces the appointment of Avirup Bose as Chief Business Officer Paris (France), 18 January, 2024 – Iktos, a company specialized in Artificial Intelligence for new drug design, announces...

Iktos and Bayer Announce Collaboration to expand the use of Artificial Intelligence to Design New Sustainable Crop Protection Solutions Paris, France, December 14, 2023 – Iktos, a company specialized...

Kissei introduces Iktos AI Drug Discovery System Paris, France, July 3, 2023 – Iktos, a company specialized in Artificial Intelligence for new drug design, today announced that Kissei...

Kissei introduces Iktos AI Drug Discovery System Paris, France, July 3, 2023 – Iktos, a company specialized in Artificial Intelligence for new drug design, today announced that Kissei Pharmaceutical...